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Abstract 
Most studies of responses to transcriptional stimuli measure changes in cellular mRNA concentrations.  
By sequencing nascent RNA instead, it is possible to detect changes in transcription in minutes rather 
than hours, and thereby distinguish primary from secondary responses to regulatory signals.  Here, we 
describe the use of PRO-seq to characterize the immediate transcriptional response in human cells to 
celastrol, a compound derived from traditional Chinese medicine that has potent anti-inflammatory, 
tumor-inhibitory and obesity-controlling effects.  Our analysis of PRO-seq data for K562 cells reveals 
dramatic transcriptional effects soon after celastrol treatment at a broad collection of both coding and 
noncoding transcription units.  This transcriptional response occurred in two major waves, one within 10 
minutes, and a second 40-60 minutes after treatment.  Transcriptional activity was generally repressed 
by celastrol, but one distinct group of genes, enriched for roles in the heat shock response, displayed 
strong activation.  Using a regression approach, we identified key transcription factors that appear to 
drive these transcriptional responses, including members of the E2F and RFX families.  We also found 
sequence-based evidence that particular TFs drive the activation of enhancers.  We observed increased 
polymerase pausing at both genes and enhancers, suggesting that pause release may be widely inhibited 
during the celastrol response.   Our study demonstrates that a careful analysis of PRO-seq time 
course data can disentangle key aspects of a complex transcriptional response, and it provides new 
insights into the activity of a powerful pharmacological agent.   
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Introduction 
The technique of perturbing cells and then measuring changes in their patterns of gene 
expression is a reliable and widely used approach for revealing mechanisms of homeostatic 
regulation.  In mammalian cells, a wide variety of stimuli that induce striking changes in 
transcription are routinely applied, including heat shock, hormones such as estrogen, androgen 
and cortisol, lipopolysaccharide, and various drugs.  Regardless of the stimulus, transcription 
is commonly assayed by measuring concentrations of mature mRNA molecules, typically using 
RNA-seq.  This approach is now relatively straightforward and inexpensive, and allows for the 
use of standard analysis tools in detecting many transcriptional responses1,2.    
Nevertheless, these mRNA-based approaches are fundamentally limited in temporal 
resolution owing to the substantial lag between changes in transcriptional activity and 
detectable changes in the level of mRNAs.  This lag results in part from the time required for 
transcription and post-transcriptional processing, and in part because pre-existing mRNAs 
buffer changes in mRNA concentration. For a typical mammalian gene, significant changes may 
require hours to detect, making it difficult to distinguish primary responses to a signal from 
secondary regulatory events. A possible remedy for this limitation is instead to make use of 
GRO-seq3, PRO-seq4, NET-seq5–7, or related methods8–11 for assaying nascent RNAs.  These 
assays have the important advantage of directly measuring the production of new RNAs, rather 
than concentrations of mature mRNAs.  As a consequence, they can detect immediate changes 
in transcriptional activity, and they permit time courses with resolutions on the order of 
minutes rather than hours12–15.  An additional benefit of nascent RNA sequencing is that it 
is effective in detecting unstable noncoding RNAs, including enhancer RNAs (eRNAs), together 
with protein-coding transcription units13,16,17.  As a result, both active regulatory elements 
(which are generally well marked by eRNAs) and transcriptional responses can be 
detected using a single assay18.  
In this study, we sought to use PRO-seq to characterize the immediate, dynamic 
transcriptional response to the compound celastrol.  Celastrol (also known as tripterine) is a 
pentacyclic triterpenoid isolated from the root extracts of Tripterygium wilfordii (thunder god 
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vine), which has been used for millennia in traditional Chinese medicine for treatment of 
fever, joint pain, rheumatoid arthritis, bacterial infection, and other ailments19.  During the past 
few decades, celastrol has shown promise as an anti-inflammatory agent in animal models of 
collagen-induced arthritis, Alzheimer disease, asthma, systemic lupus erythematosus, and 
rheumatoid arthritis20–24.  In addition, it is known to inhibit the proliferation of tumor cells, 
including those from leukemia, gliomas, prostate, and head/neck cancer24–27.  Recent research 
has also demonstrated striking obesity-controlling effects in mice28,29.  Celastrol is known to 
activate the mammalian heat shock transcription factor HSF1 and stimulate the heat shock 
response19,30 as well as the unfolded protein response27,31, and to activate a battery of 
antioxidant response genes30.  Celastrol also inhibits the activities of other transcription factors, 
including androgen receptor32, glucocorticoid receptor30 and NF-KB24 . Nevertheless, much 
remains unknown about the mechanism of action by which celastrol affects transcription.  In 
particular, little is known about the immediate transcriptional effects or primary targets of 
celastrol.  Thus, an examination using PRO-seq provides an opportunity for a deeper 
understanding of the mechanisms underlying the activity of this potent compound which has 
potential therapeutic implications.  
We collected PRO-seq data for K562 cells at tightly spaced time points after treatment 
with celastrol and analyzed these data using a variety of computational methods.  Our analysis 
revealed dramatic transcriptional effects within minutes of celastrol treatment at a large, 
diverse collection of both coding and noncoding transcription units.  We observed a general 
pattern of transcriptional repression, but saw activation in a group of genes enriched for 
roles in the heat shock response.  By analyzing the associated sequences, we were able to 
identify numerous transcription factors that appeared to drive the transcriptional responses at 
both genes and enhancers. Interestingly, we also observed a clear impact from celastrol 
treatment on polymerase pausing at both genes and enhancers, suggesting that pause release 
may be widely inhibited during the celastrol response.  Finally, changes in pausing were 
negatively correlated with changes in transcriptional activity, suggesting that pausing may 
contribute to the response to celastrol. Altogether, our analysis demonstrates that time-
courses of PRO-seq data together with appropriate bioinformatic analyses can be used to 
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dissect key aspects of a complex transcriptional response at both regulatory elements and 
target genes.   
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Figure 1. Characterizing the dynamic transcriptional response to celastrol using PRO-seq. (A) PRO-seq was applied to 
K562 cells collected before celastrol treatment (untreated or 0 minutes) and at 10, 20, 40, 60, and 160 minutes after celastrol 
treatment. Two biological replicates were performed for each time point (B) Distribution of log expression ratios (treated vs. 
untreated) for each time point (rlog is a regularized log2 estimate obtained from DESeq2).  Only genes classified as differentially 
expressed (DE) throughout the time course are represented.  Notice that most DE genes (FDR ≤ 0.01) are down-regulated upon 
celastrol treatment. (C) A UCSC Genome Browser display showing raw PRO-seq data for two differentially expressed genes, 
EGR1 and KDM3B. EGR1 is rapidly and strongly repressed (immediate decrease of ~80%), whereas KDM3B is more gradually 
repressed, losing ~50% of its expression by 160 minutes.   
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Results 
Celastrol induces broad transcriptional repression and more limited up-regulation 
We prepared PRO-seq libraries for K562 cells before celastrol treatment and after 10, 
20, 40, 60, and 160 minutes of celastrol treatment, with two biological replicates per time point 
(Figure 1A). To ensure that we could normalize read counts even in the presence of global 
changes in transcription, we spiked in to each sample an equal number of permeable 
Drosophila cells prior to run-on33. Samples were sequenced to a total combined depth of 
334.3M reads, with an average replicate concordance of r298% (Supplemental Figure 1). About 
0.5M of these reads (0.1%) were derived from the Drosophila spike in.  To obtain gene models 
appropriate for our cell types and conditions, we developed a probabilistic method, called 
tuSelector, that considers all annotated isoforms for each gene and identifies the most likely 
gene model given our PRO-seq data (Supplemental Figure 2, Supplementary Methods). We 
identified a total of 12,242 protein-coding genes from GENCODE as being actively transcribed in 
one or more time-points (Methods).  Of these genes, 75.4% were active across all six time 
points, 11.7% were active in a single time-point, and the remaining 12.9% were active in 2-5 
time-points. Thus, our PRO-seq data and computational analyses indicate that more than half of 
all protein-coding genes are transcribed either in the basal condition or during the celastrol 
response in K562 cells. 
The genes that are differentially transcribed in response to celastrol were of particular 
interest for further analysis. To measure transcriptional activity specific to each time point, we 
used counts of PRO-seq reads mapping to the first 16 kb of each gene body.  Because RNA 
polymerase travels at an average rate of ~2 kb/min12,14,34,35 and our time points are separated 
by at least 10 minutes, this strategy conservatively considers new transcription only, yet 
maintains sufficient statistical power for downstream analysis (see Methods). By applying 
DEseq236 to these 16-kb read counts, we identified 6,516 (56%) of the active genes as being 
differentially expressed (DE) relative to the untreated condition (FDR ≤ 0.01). Interestingly, 
~80% of these DE genes were down-regulated.  Many genes showed rapid and dramatic down-
regulation, with decreases in expression by half or more at 3.5% of DE genes within 10 minutes, 
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at 7.8% of DE genes within 20 minutes, and at 48.1% of DE genes within 160 minutes (Figure 
1B&C). By contrast, many fewer genes showed substantial increases in expression; for example, 
only 0.03%, 1.9%, and 7.7% of DE genes had doubled in expression after 10, 20, and 160 
minutes, respectively. Nevertheless, extreme up- and down-regulation were both rare, with 
<1% of DE genes showing increases and <1% showing decreases in transcription by factors of 
eight or more. These observations are reminiscent of findings for the heat shock response, 
which have included general decreases in transcription together with up-regulation of selected 
stress-response elements15,37, but the effect of celastrol is somewhat less dramatic. We 
conclude that celastrol broadly inhibits transcription within minutes after administration but 
also rapidly activates a set of genes that may be important for continued cellular viability. 
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Figure 2 Induction of cellular stress responses by celastrol. (A) Illustration showing key aspects of the unfolded 
protein response (UPR) and heat shock response (HSR), both of which have been reported to be induced by celastrol30,31. 
Expected transcriptional targets are shown inside the nucleus, with targets of HSF1, the key transcription factor (TF) activated in 
the HSR, in red, and targets of the TFs associated with the three major branches of the UPR—XBP1, ATF4, and ATF6—in green, 
purple, and blue, respectively. Asterisks indicate genes that were differentially expressed in our experiments with FDR ≤ 0.01. (B) 
PRO-seq-based log fold changes in expression in K562 cells after 160 minutes of treatment by celastrol for numerous known 
targets of the same four TFs: XBP1, ATF4, ATF6, and HSF1.  Only targets of HSF1 display strong up-regulation. 
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Celastrol activates heat shock more strongly and directly than it activates the unfolded 
protein response  
Celastrol has been reported to activate stress response pathways such as the heat shock 
and unfolded protein responses19,27,30,31.  To see whether these effects were detectable at the 
transcriptional level immediately after treatment with celastrol, we examined our PRO-seq data 
at genes activated by heat shock factor protein 1 (HSF1) and genes involved in the three 
branches of the unfolded protein response (UPR), corresponding to activating transcription 
factor 6 (ATF6), inositol-requiring enzyme 1 (IRE1), and endoplasmic reticulum kinase (PERK) 
(Figure 2A). Because the initial stages of the UPR and heat shock response are non-
transcriptional, we looked for downstream activity of the first group of transcription factors 
activated in each pathway, using targets reported in the Reactome pathway database38. Most 
direct targets of HSF1 were up-regulated within 160 minutes (Figure 2B).  Genes encoding 
chaperone protein HSP110 and proteinase inhibitor CBP1 were among the HSF1 targets 
showing the strongest initial response, with the gene encoding HSP110 almost quadrupling its 
expression in 10 minutes and that for CBP1 increasing more than eight-fold in 160 minutes.  
Most direct targets of ATF4, ATF6, and XBP1, however, were not strongly induced during our 
time course. There were some exceptions to this general rule, such as genes encoding 
transcription factor ATF3, chaperone BiP, and apoptosis inhibitor DNAJB9, which more than 
doubled in expression. It is possible that these targets are activated earlier than other targets, 
perhaps by other TFs. In any case, our observations suggest that celastrol induces a 
pronounced, rapid transcriptional response in the heat shock pathway, and has a much less 
pronounced transcriptional effect on the UPR, although some targets of the UPR are activated. 
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Figure 3. Clusters of genes showing distinct temporal patterns of response to celastrol. (A) Differentially expressed 
genes (FDR ≤ 0.01) clustered by time series of log fold change (LFC) in expression relative to the untreated condition (0 minutes). 
Each gene is represented by a blue line, and the red lines indicate the mean expression per timepoint per cluster. Below each 
cluster is a summary of the most strongly enriched terms in the Reactome ontology38 (FDR ≤ 0.01; see Supplementary Material 
for details).  Clusters #4 and #6 did not show coherent enrichments. (B) ChIP-seq data from reference 42 describing binding of 
HSF1 in K562 cells under normal (left) and heatshock (right) conditions, stratified by our cluster assignments.  Each line 
represents an average over all genes in the cluster in the region of the TSS, with lighter-colored bands representing 95% 
confidence intervals obtained by bootstrap sampling.  Notice that cluster three is unique in showing a strong enrichment for 
heatshock-induced binding of HSF1. 
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Celastrol produces distinct temporal patterns of transcriptional response 
Our PRO-seq data for closely spaced time points enabled us to examine the temporal 
patterns of transcriptional response to celastrol treatment across the genome. Using an 
autoregressive clustering algorithm, EMMIX-WIRE39, we partitioned our ~12,000 DE genes into 
six distinct clusters, based on their patterns of relative transcription across the five time points 
following celastrol treatment (see Methods) (Figure 3A). Only one of these clusters (cluster #3) 
displayed dramatic and sustained up-regulation.  By contrast, cluster #4 showed transient, 
weak activation followed by down-regulation, cluster #2 showed rapid and pronounced down-
regulation, clusters #1 and #6 displayed moderate, continuous down-regulation, and cluster #5 
showed delayed down-regulation.  Interestingly, the change points in the expression patterns 
for these clusters suggested that the transcriptional response to celastrol occurs largely in two 
distinct waves, one within the first ten minutes, and a second between 40 and 60 minutes. 
These findings were robust to the number of clusters selected, with similar overall behavior for 
five-, six-, and seven-cluster models (Supplemental Figure 3&4).  
Four of these six clusters could be associated with fairly coherent biological functions, 
according to the Reactome ontology (Fig 3A). In particular, cluster #1 contains essential 
elements of the RNA splicing machinery (e.g., CD2BP2, CLP1, and the SRSF kinase family) 
(Supplemental Figure 5).  Down-regulation of this cluster is consistent with previous reports 
that splicing is inhibited under heat shock40. Cluster #2 is enriched for a wide variety of terms 
corresponding to ribosomal assembly, translational initiation, and peptide elongation.  The 
pronounced transcriptional repression of this cluster, together with activity of HSPB1 (HSP27) 
and HSPA2 (HSP70), is consistent with reports that celastrol activates the heat shock response 
and thereby inhibits translation via HSPB1 in the absence of HSP7041 (Supplemental Figure 
6&7). Cluster #3 is enriched for genes responsible for the HSF1 response, including the HSPA 
family (Supplemental Figure 8). In addition, many genes in this cluster have been shown, by 
ChIP-seq, to bind by HSF1 under heat shock conditions in K562 (Figure 3B)42. Cluster #4 is 
enriched for genes associated with cargo transport (Supplemental Figure 9). Finally, cluster #5 is 
enriched for pathways that enable DNA replication (e.g., MCM family) and cell cycle progression 
(e.g., CDK family; Supplemental Figure 10).  The delayed down-regulation of these genes may 
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occur as the cell is preparing to enter replicative arrest and, potentially, senescence, consistent 
with observations that celastrol induces cell cycle arrest and potentiates apoptosis27,43,44. 
Clusters #4 and #6 did not exhibit striking functional enrichments. Similar patterns of 
enrichment were observed with five- and seven-cluster models.  Overall, these results 
demonstrate that the components of a complex, multi-layered transcriptional response can be 
disentangled, to a degree, by identifying groups of genes that display distinct temporal patterns 
of gene expression.    
  
.CC-BY-NC-ND 4.0 International licensea
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under 
The copyright holder for this preprint (which was notthis version posted March 16, 2017. ; https://doi.org/10.1101/117689doi: bioRxiv preprint 
Figure 4. The celastrol response appears to be influenced by various transcription factors (TFs). Shown are the estimated 
weights from the regression model to predict PRO-seq-measured transcription levels from TF-specific DeepBind scores in the 
promoter regions of differentially expressed genes. A positive weight for a TF at given timepoint indicates that genes at which 
that TF is predicted to be bound showed increased expression relative to those without it. Negative weights indicates decreased 
expression. The three separate plots represent clusters of TFs associated with distinct temporal patterns.  
 
Several key transcription factors are associated with the celastrol response 
Can the distinct transcriptional responses in these clusters of genes be traced to 
particular transcription factors (TFs)?  To address this question, we used linear regression to 
explain the estimated transcription levels at each time point based on the TFs that apparently 
bind in the promoter region of each gene. We used two orthogonal sources of information 
about TF binding: (1) ChIP-seq peaks for untreated K562 cells45; and (2) sequence-based 
computational predictions based on DeepBind46.  In both cases, we considered the interval 
between 500bp upstream and 200bp downstream of the transcription start site of each active 
gene.  Our regression model included a coefficient for each TF at each time point.  A positive 
estimate of this coefficient indicated that a given TF and its binding sites were associated with 
up-regulation at a given time point, whereas a negative estimate indicated that the TF and 
binding sites were associated with down-regulation at that time point. 
Between the two TF binding datasets, we identified over twenty TFs as being 
significantly associated with changes in gene expression and having a large change in effect size 
(Figure 4, Supplemental Figure 11). Of these TFs, E2F4 stood out as showing a particularly 
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pronounced impact on expression in both datasets. E2F4 is associated with incrementally 
increased expression between 0 and 60 minutes, and with decreased expression thereafter, 
similar to the expression pattern of genes in cluster five, which are associated with cell cycle 
control. This observation is consistent with reports that E2F4 is an activator in some contexts 
but primarily acts as a repressor responsible for maintaining G2 arrest47,48.  
In addition, we found that the dimerizing TFs MYC (from ChIP-seq data) and MAX (from 
DeepBind predictions) were both associated with an immediate increase in gene expression, 
followed by decreased expression within 20 minutes (Figure 4). This delayed decrease in 
expression of MYC- and MAX-bound genes could result from the known disruption of MYC-MAX 
dimerization by celastrol19,49. Finally, genes predicted to be bound by SRF also displayed 
elevated gene expression after 40 minutes. SRF has been previously associated with early and 
transient induction of cytoskeletal genes in response to heat stress in murine embryonic 
fibroblasts15. 
Finally, we found that the paralogous TFs RFX1 (from ChIP-seq) and RFX5 (from 
DeepBind) were both associated with increases in expression.  Both of these TFs have been 
implicated in regulating MHC-II expression and both have context-specific transcriptional 
repression and activation mechanisms50–52, so it is possible that they contribute to celastrol’s 
anti-inflammatory effects. However, RFX1 was not tested with DeepBind and its motif is quite 
similar to that of RFX5 so it is impossible to know from our data whether one or both of these 
TFs are important in the celastrol response (notably, they do have different binding patterns in 
vivo in the untreated condition; Supplemental Figure 11B,C). Nevertheless, our regression 
framework is useful in providing a list of candidate TFs whose binding preferences correlate 
with aspects of the celastrol response.  
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Figure 5. Increased promoter-proximal pausing is associated with transcriptional repression in the response to 
celastrol. (A) Mean PRO-seq signal at promoters for all active genes, grouped by time point and oriented with respect to the 
direction of transcription of the gene. X-axis represents distance to the center of the divergent transcription start site (see 
Methods).  Intervals around each line represent 95% confidence intervals obtained by bootstrap sampling. Notice the general 
increase in the height of the pause peaks with time.  (B) The distribution of changes in the log fold index with respect to the 
untreated condition (ΔLPI; see Methods) for all active genes at each time point. (C) The distribution of ΔLPI for all DE genes (FDR 
≤ 0.01) by cluster and time-point. Notice that all clusters show an increase in the pause index with time, except for cluster three.  
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Increased polymerase pausing is broadly associated with transcriptional repression 
Promoter-proximal pausing of RNA polymerase is a rate-limiting and independently 
regulated step in productive transcription53,54. Notably, the peaks of paused RNA polymerase at 
DE genes doubled in height during our time course (Figure 5A). Accordingly, we found that the 
“log pause index,” or log2 ratio of average read depth at the pause peak to that in the proximal 
gene body, increased by more than 1 (corresponding to a fold-change of more than 2 in the 
pause index) in DE genes by 160 minutes (Figure 5B). Together, these observations indicate that 
most DE genes undergo increased pausing after celastrol treatment, suggesting that pause 
release may be widely inhibited during the celastrol response. 
To see if particular expression patterns were associated with changes in pausing, we 
separately examined the changes in log pause index during the time course for each of our six 
gene expression clusters. Interestingly, we found that pausing increased in all clusters with the 
exception of cluster #3 (Figure 5C), the only strongly up-regulated cluster (see Figure 3A), 
where it remained essentially unchanged. Thus, changes in the log pause index are generally 
negatively correlated with changes in expression across clusters. This observation suggests that 
decreases in the release of paused Pol II to productive elongation could contribute to increased 
pausing and, hence, to down-regulation of transcription, while the absence of such an effect (in 
cluster #3) might permit up-regulation of transcription15,56. As cluster #3 is strongly associated 
with the HSF1 response, this finding is consistent with previous reports that HSF1 regulates 
transcription by increasing the rate of release of paused RNA polymerase into productive 
elongation15.  
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Figure 6. Response to celastrol at predicted transcribed enhancers. (A) Divergent transcription start sites (dTSS) that 
were classified by distance-based rules as likely enhancers or promoters show distinct patterns of histone marks in untreated 
K562 cells.  Shown are H4K4me1 (enriched at enhancers), H3K4me3 (enriched at promoters), and H3K27ac (enriched at both). 
PRO-seq read counts are shown for comparison.  X-axis is oriented by direction of transcription of nearest gene. (B) Gene 
Ontology (GO) biological processes associated with DE transcribed enhancers using GREAT59. Bar plot represents –log10 p-values 
for enrichment, with numerical fold enrichments indicated at right. (C) Metaplot of PRO-seq signal at all enhancers, centered on 
the dTSS, per timepoint.Units of PRO-seq signal are average numbers of reads per 10bp bin.   Intervals around each line 
represent a 95% confidence interval obtained by bootstrap sampling. 
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Enhancers show similar functional associations and pausing patterns to genes 
Previous studies have shown that putative enhancers are divergently transcribed, 
producing nascent RNAs that can be detected via PRO-seq17,18,57. Using the dREG prediction 
method58, we identified 25,891 apparent divergent transcription start sites (dTSS) from our 
PRO-seq data, pooling data across time points. Based on the distance from nearest annotated 
TSS, we classified 7,334 of these dTSS as likely transcribed enhancers, 15,941 as likely 
promoters, and the remaining 2,616 as ambiguous. For validation, we examined ChIP-seq data 
from ENCODE for untreated K562 cells, and found, as expected, that enhancer and promoter 
classes were both strongly enriched for acetylation of histone H3 at lysine 27 (H3K27ac), and 
that the promoter class was more strongly enriched for RNA polymerase and trimethylation of 
histone H3 at lysine 4 (H3K4me3) (Figure 6A). The enhancer class also showed moderate 
enrichment for monomethylation of histone H3 at lysine 4 (H3K4me1). These observations 
confirm that PRO-seq serves as an efficient single-assay approach for characterizing both 
transcribed enhancers and protein-coding genes58.  
To better understand the role of the non-coding regulatory elements in the celastrol 
response, we further examined 1,479 (~20%) of the 7,334 dTSS-based enhancers that were 
classified as differentially transcribed.  We attempted to find functional enrichments for 
potential target genes of these differentially transcribed enhancers using the Genome Regions 
Enrichment of Annotations Tool (Ver. 3.0) (GREAT59; see Methods). GREAT identified 
enrichments for processes relating to apoptosis, translational regulation, and responses to 
various environmental stresses (Figure 6B), in general agreement with our analysis of DE genes. 
We also found that our set of putative enhancers displayed an accumulation of paused 
polymerase after celastrol treatment (Figure 6C)(Supplemental Figure 12). Although the 
functional significance of pausing at enhancers is unknown, this observation suggests that 
global shifts in pause levels at genic TSS are also reflected at enhancers. 
Lastly, we sought to determine which TFs influenced activity at a relatively small group 
of 480 enhancers that showed little activity at 0 minutes but greatly increased activity by 160 
minutes. We compared DeepBind scores for these activated enhancers with those for non-DE 
enhancers that had similar absolute expression levels and found six TFs with significantly 
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elevated scores in the activated enhancers: HSF2, JUND, FOSL2, MAFK, STAT3, and THRA 
(Supplemental Figure 13; Figure 6D). Of these TFs, HSF2, was also associated with increased 
expression in genes, while JUND and FOSL2 are subunits of AP-1, a TF previously found to 
regulate cellular growth and senescence60. Because these TFs were identified simply based on 
their sequence preferences, TFs with similar motifs are also potential regulators. For example, it 
is possible that JUN, whose expression increases over the time course and which is known to be 
activated by HSF161, is actually responsible for the apparent association with JUND, which does 
not appear to be activated.  Together, these results demonstrate that PRO-seq can be used to 
detect transiently activated enhancers and identify TFs that may drive the enhancer response. 
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Discussion 
This study represents the first genome-wide assessment of the immediate 
transcriptional effects of celastrol, including transcribed regulatory elements as well as genes, 
shedding light on some of the possible primary targets and mechanisms of action of this potent 
therapeutic compound.  We find that celastrol treatment results in pervasive transcriptional 
down-regulation, with nearly half of expressed genes being down-regulated within 160 
minutes.  A much smaller group of genes, roughly 10% of those expressed, are up-regulated 
during the same time interval. By analyzing the sequences nearby transcription units, we were 
able to identify several transcription factors whose binding patterns partially explain these 
transcriptional responses.  We also observed a clear impact from celastrol on polymerase 
pausing at both genes and enhancers, which is negatively correlated with changes in 
transcriptional activity.  While there are limits to what can be learned from PRO-seq data alone, 
we have shown that when these data are collected at relatively high temporal resolution and 
analyzed together with other data for the untreated condition, they can provide valuable 
insights into a multifaceted, multistage cellular response to a transcriptional stimulus.  
We find that celastrol treatment generally induces a similar response to heat shock, 
consistent with previous reports19,30. Heat-shock has also been observed to induce widespread 
down-regulation in mammalian cells15,37.  Moreover, many of the same genes that are up-
regulated upon celastrol treatment are also bound by HSF1 after heat shock or participate in 
heat-shock pathways.  Finally, sequences associated with HSF1 binding are associated with 
increased gene expression, according to our regression analysis. Together, these findings 
suggest that HSF1 is activated soon after celastrol treatment, whereupon it activates a large 
group of genes. 
These observations suggest that, in part, the transcriptional response to celastrol may 
simply be a general cellular stress response. Cellular stress responses are known to affect a 
broad range of cellular functions, including cell cycle arrest, transcription of molecular 
chaperones, activation of DNA damage repair pathways. removal of irretrievably damaged 
macromolecules, and apoptosis upon severe damage62, and they are relevant in many diseases, 
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including cancer63, proteotoxic diseases31, and autoimmune disorders64. Previous studies have 
investigated cellular stress responses at the delayed transcriptional15,65, post-transcriptional66, 
translational40, and post-translational levels67,68.  Together with similar studies of heat shock15, 
our study is valuable in illuminating features of the early transcriptional response to stress.  
Nevertheless, we observed differences between the heat shock and celastrol responses. 
For instance, we found that binding sites for SRF, a transcription factor associated with HSF1/2-
independent up-regulation after heat-shock, are enriched in the core promoters of genes 
having elevated expression after 40 minutes15. By contrast, previous findings for heat shock15 
have indicated that the positive effect on gene expression occurs as early as 2.5 minutes after 
treatment, suggesting that there may be some kinetic differences between the celastrol and 
heat-shock responses. Our analysis also suggests that the loss of binding by MYC-MAX may be 
responsible, in part, for the broad transcriptional repression within 20 minutes of celastrol 
treatment. This finding is supported by previous studies showing that celastrol directly inhibits 
MYC-MAX functionality49. Since MYC-MAX is a strong transcriptional activator and is bound at 
over 6,000 promoters of active genes in K562, its inhibition may be an important contributing 
factor to widespread down-regulation after celastrol treatment69,70. To our knowledge, MYC-
MAX inhibition has not been reported to be important in the heat-shock response, but if it is, 
this inhibition is likely to be due to a different mechanism.  
A major strength of our experimental approach is that it allows us to observe transient 
as well as sustained transcriptional responses. For example, we found that E2F4 was quickly 
down-regulated after celastrol treatment, reducing in expression by half within 20 minutes, but, 
nevertheless, target genes of this transcription factor were increasingly repressed later in our 
time course (between 60 and 160 minutes).  These observations suggest that the apparent 
increased activity of E2F4 during the celastrol response may have a non-transcriptional basis; 
for example, perhaps pre-existing E2F4 is post-translationally modified to become more active. 
Interestingly, previous studies have shown that celastrol inhibits CDK4, and that CDK4 
overexpression disrupts E2F4 DNA-binding ability71,72. Thus, it is possible that celastrol 
treatment frees up E2F4 to bind DNA, which in turn could contribute to cell-cycle arrest47,48.  
.CC-BY-NC-ND 4.0 International licensea
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under 
The copyright holder for this preprint (which was notthis version posted March 16, 2017. ; https://doi.org/10.1101/117689doi: bioRxiv preprint 
Another advantage of our densely sampled PRO-seq time course is that it allows us to 
measure changes in promoter-proximal RNA polymerase pausing. We observed that pause 
indices increased by more than two-fold at differentially expressed genes during our time 
course.  We also found that increase pausing was associated with decreased transcription in 
genes, as previously reported for heat-shock conditions15, although we did not observe a 
converse association between decreased pausing and up-regulation of genes. A possible 
mechanism behind this increased pausing is the disruption of the MYC-MAX complex, which has 
been shown to recruit P-TEFb, which in turn facilitates pause release73. This mechanism could in 
principle affect down-regulated genes only, for example, if up-regulated genes recruit P-TEFb 
independently of MYC-MAX (e.g., through binding of HSF174).  
While it is possible that increased pausing causes decreased expression, by limiting 
productive elongation and therefore reducing transcription levels, an alternative possibility is 
that decreased transcriptional activity across many genes results in increased availability of free 
Pol II, some of which ends up being loaded on promoters and coming to rest at pause sites15.  In 
other words, the negative correlation between pausing and expression could be explained by 
causality in either direction, or perhaps in both directions.  Additional experiments will be 
needed to establish the causal basis of these correlations.  In any case, our observations 
suggest that changes in pausing are widespread and broadly associated with transcriptional 
repression, and therefore may play an important role in the celastrol response.  
Materials and Methods 
Celastrol treatment  
 K562 cells were cultured at 37 °C in RPMI media (Gibco) containing 10% FBS (Gibco), 
Pen Strep (Gibco) and 2 mM L-Glutamine (Gibco). Biological replicate cell cultures were 
prepared as follows: after thawing K562 cells and seeding a fresh culture, cells were split into 
two separate flasks, which would remain separated through six passages and expansions until 
treatment and collection for preparation of PRO-seq libraries.  Cells from each expanded 
replicate were seeded onto six 30-mL dishes (one for each time point) at a density of 5x105 
cells/mL and then incubated for an additional doubling cycle (~20 hrs).  For treatments, fresh 
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celastrol was dissolved in DMSO at a final concentration of 20 mM.  Celastrol-treated samples 
received celastrol (Sigma) at a final concentration of 3 μM, whereas untreated (0-minute) 
samples received an equivalent volume of DMSO.  Cells remained in culture dishes in the 
incubator during the time course. Time-course treatments were carried out in reverse order so 
that all samples would be collected at the same time (starting with 160-minute time point and 
ending with the untreated). 
Cell permeablization and PRO-seq 
Samples were then prepared for precision run-on reactions by subjecting cells to 
permeablizing conditions.  Briefly, cultures were spun down and resuspended in ice cold 1xPBS.  
Samples were spun again and washed in 5 mL wash buffer (10 mM Tris-Cl, pH 7.5; 10 mM KCl; 
150 mM sucrose; 5 mM MgCl2; 0.5 mM CaCl2; 0.5 mM DTT; 1x Protease inhibitor cocktail 
(Roche); 20 units RNase inhibitor (SUPERase In, Invitrogen)). Cell pellets were then resuspended 
in permeablization buffer (10 mM Tris-Cl, pH 7.5; 10 mM KCl; 250 mM sucrose; 5 mM MgCl2; 1 
EGTA; 0.05% Tween-20; 0.1% NP40; 0.5 mM DTT; 1x Protease inhibitor cocktail (Roche); 20 
units RNase inhibitor (SUPERase In, Invitrogen)) and left on ice for 5 minutes.  Cells were 
checked for penetration by trypan blue to assess permeability (~99% permeable).  Cells were 
then washed two times in 5 mL wash buffer before being resuspended in 200 μL storage buffer 
(50mM Tris-Cl, pH 8.3; 40% glycerol; 5 mM MgCl2; 0.1 mM EDTA; 0.5 mM DTT).  A one-to-fifty 
dilution was prepared using 2 μL of each sample and used to take OD600 measurements.  All 
samples were then diluted to an equal density (OD600 = 0.181) in a final volume of 110 μL of 
storage buffer. 5x104 pre-permeabilized S2 cells were then spiked in to each cell count-
normalized sample before flash-freezing the permeablized cells and storing them at -80 °C.    
Stored permeable cells with spike-ins were thawed on ice and each sample was 
subjected to the precision run-on protocol75. Run-on reactions incorporated only biotinylated 
NTPs with no un-modified NTPs.  All libraries were subjected to nine cycles of PCR amplification 
before size selection and gel purification.  
Read mapping 
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All filtered reads were removed from each fastq file, then cutadapt (v1.9.1) was run with 
the following options: 
cutadapt -a TGGAATTCTCGGGTGCCAAGG -m 15 
to remove the Illumina adapters and discard all remaining reads that were less than 15bp in 
length. All reads were then trimmed to 34bp in length using fastx_timmer (v0.0.13.2) to avoid 
biasing read mapping away from gene promoters. The trimmed reads were then aligned to the 
joint hg19/bdgp6 genome using the STAR aligner (v2.4.0i). Reads aligning to hg19 and bdgp6 
were then separated and bigwigs were created by converting each read to a single count at its 
5’ end.  
Detection and resolution of dTSS 
dREG was run on each sample as described previously58, producing a set of genomic 
intervals corresponding to predicted divergent transcription starts sites (dTSS). These initial 
dREG calls had fairly coarse resolution, ranging in size from several hundred to thousands of 
bases.  We therefore applied a heuristic scanning method to identify one or more higher-
resolution dTSSs within each dREG call.  Briefly, this method involved sliding a window along a 
dREG interval and considering the relative read counts among three subintervals: a peak, a 
flank, and center.  To identify pairs of divergent peaks, the test was applied simultaneously to 
each strand in a strand-specific manner, and the results were combined.  Specifically, for a scan 
initiated at base 𝑖, the center was defined as the interval [𝑖, 𝑖 + 110), the shoulder as [𝑖 −
50, 𝑖), and the flank as [𝑖 − 250, 𝑖 − 150) (Supplemental Figure 2). Three one-sided binomial 
tests were performed, testing that there are fewer reads in the center than the flank, the 
center than the shoulder, and the flank than the shoulder. The sum of the resulting six negative 
log p-values (three for each strand) then became the per-base score.  The best scoring window 
in a dREG region was taken as a dTSS. In addition, up to two other dTSSs were called if their 
score exceeded 20. 
Classifications of dTSS 
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 dTSS were classified as either enhancers or promoters based on their relative distance 
from the set of all TSSs annotated in GENCODE v19. To classify each dTSS, the following rules 
were applied: (1) if the dTSS was greater than 1 kb, and at most 1 Mb, away from the nearest 
annotated promoter, it was classified as an enhancer; (2) if the dTSS was within 200 bp of an 
annotated promoter, or it was within 1 kb of an annotated promoter and it was the closest 
dTSS to the promoter, it was classified as a promoter; (3) if the dTSS was between 600bp and 1 
kb away from the nearest annotated promoter, and not the closest dTSS to the promoter, It 
was classified as an enhancer; (4) otherwise, the dTSS was classified as unknown.  
Selection of active transcripts in K562 cells 
Selection of transcripts was performed by a new program, called TuSelector. First, a list 
of potential transcripts was obtained from GENCODE v19. The genic regions and data were 
partitioned into 100bp intervals. For each gene, a set of coarse-grained overlapping transcript 
models was created, where for each transcript model and interval, the interval was assigned to 
the transcript model if, and only if, it overlapped the corresponding annotated transcribed 
region by more than 50% at the nucleotide level. Next, the PRO-seq read counts in each 100 bp 
interval were summarized by a 1 if there were reads aligned to the interval or a 0 otherwise. 
TuSelector computed a likelihood for each of the possible coarse-grained transcript models at a 
given gene, as follows: 











where 𝑇 is the transcript model, the products range across genomic intervals i, 𝑥𝑖 is the 
summary of the data in interval i (0 or 1), 𝛿(𝑖, 𝑇) is an indicator function that takes value 1 
when interval i is included in 𝑇 and 0 otherwise, 𝑋 is a Bernoulli random variable, and 𝜃𝑡  and 𝜃𝑢  
are the parameters for this random variable in the transcribed and untranscribed states, 
respectively.  𝑃(𝜃𝑡) is assumed to be uniform over the interval (0.3, 1), and 𝑃(𝜃𝑢) is assumed 
to be uniform over the interval (0.01, 0.03). In practice, we discretized 𝜃𝑢 into segments of size 
0.01 and 𝜃𝑡  into segments of size 0.05, and approximated the integrals with finite sums. Finally, 
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in addition to the annotated transcripts, we considered a competing model representing a 
completely untranscribed gene.  
TuSelector was run separately for each replicate and time point, and potentially 
produced discordant transcript calls across these runs.  Therefore, we selected at most one 
“consensus” transcript model per gene for use in further analysis, as follows. To be considered 
a consensus call, TuSelector had to identify the same transcript model at least 80% of the time 
with at least 50% of replicate pairs both having the same transcript call. Two transcript models 
were considered “the same” if their endpoints differed by less than 500bp.  If no transcript 
model met these criteria, the gene was not considered in further analysis.  
Estimating expression and detecting differentially expressed genes 
For all active, protein-coding transcripts, reads were taken from up to the first 16 kb of 
the gene, minus the first 500bp to avoid an influence from promoter-proximal pausing. This 
strategy allowed us to focus on the most recent transcription at each time point and avoid 
averaging over time.  The maximum interval of 16 kb was based on a minimum interval 
between time points of 10 minutes and an average polymerase transcription rate of ~2 kb/min, 
minus a few kilobases of “padding”. Any genes that were shorter than 700 bp were removed 
from the analysis. A size factor for each sample was obtained by taking the number of spike in 
reads per sample divided by the median number of spike in reads per sample. To estimate 
expression of transcriptional enhancers, reads were taken from 310 bases (assuming a 110 base 
spacing between dTSS as reported by Core et al. plus 100bp to either side) centered on the 
dTSS. Both sets of read counts were fed jointly into DESeq2, and enhancers and genes were 
subsequently separated for further analysis. An enhancer or gene was called as DE with an FDR 
≤ 0.01 using a likelihood ratio test.  
Clustering differentially expressed genes 
Gene expression log-fold changes were computed relative to the untreated (zero-
minute) time-point using the DESeq-based estimates of absolute expression (rlog values). All DE 
genes were then fed into the autoregressive clustering program EMMIX-WIRE using default 
settings. Likelihood values for between two and ten clusters were computed.  We selected six 
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clusters as a value at which the increases in likelihood with the number of clusters began to 
decline. To check for the robustness of our selection we repeated our analyses with five and 
seven clusters and found that they were not highly sensitive to the cluster number. 
Computing functional enrichment for gene clusters 
Reactome (v52) was used to assign genes to functional categories. Genes that were not 
annotated in Reactome were removed. The background set for all enrichments was the set of 
DE genes present in Reactome. Odds ratios were computed per cluster (𝑐) and pathway (𝑝) as: 
𝑂𝑅 =
𝑋𝑐,𝑝 𝑋𝑐,¬𝑝⁄  
𝑋¬𝑐,𝑝 𝑋¬𝑐,¬𝑝⁄
 
where X represents a count and 𝑐 and ¬𝑐 denote the sets of genes in, and not in, cluster 𝑐, 
respectively, and, similarly, 𝑝 and ¬𝑝 denote the sets of genes in, and not in, pathway 𝑝. An 
empirical null distribution of odds ratios was computed by randomly shuffling the gene 
assignments to pathways 100,000 times. P-values were then computed from this distribution 
and the Benjamini-Hochberg procedure was applied to estimate false discovery rates (FDRs).  
Characterizing genic regulation 
ChIP-seq data was downloaded from the ENCODE website 
(https://www.encodeproject.org) in narrowPeak format (optimal idr) on Sep. 30th, 2016. Scores 
for each gene-TF pair were computed by taking the peaks with the maximum signal that 
intersected [-200,+500] around the promoter. Deepbind v0.11 was run over [-200,+500] around 
the promoter with standard settings using all non-deprecated motifs for DNA binding proteins. 
To analyze TFs that may be involved in different regulatory patterns we linearly regressed genic 
expression (as estimated by DESeq2) against scores from ChIP-seq or DeepBind with time point 
specific coefficients for each TF and a time agnostic, gene-specific coefficient to capture the 
fixed effect of unmodeled regulation46,76. In this framework, the expected expression of a given 
gene 𝑖 at time 𝑗 is expressed as 
𝑌𝑖𝑗 = 𝛽𝑖 + 𝛽𝑗 + ∑ 𝛽𝑖𝑗𝑘𝑥𝑖𝑘
𝑘
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where 𝛽𝑖  is the gene-specific expression bias term, 𝛽𝑗  is a time-specific bias term, and 𝛽𝑖𝑗𝑘  is the 
coefficient for the time-point specific effect of a TF 𝑘.  Standard deviations for each coefficient 
were estimated via 1000 bootstraps. Finally, the list of TFs was filtered to keep those with FDR ≥ 
0.01 in at least one time point and with a maximal change between any two coefficients in the 
90th percentile. This procedure selected for TFs having an effect that was both statistically 
significant and of large magnitude.  
Identification and analysis of genic pause peaks 
To locate pause peaks, we scanned each active transcript (see above) greater than 1 kb 
in length in the region of the annotated TSS ([TSS − 200, TSS + 200]), taking the number of 
reads in a 50-bp sliding window, with a sliding increment of 5 bp. The window with the largest 
number of reads in the untreated condition (0-minute time point) was designated as the pause 
peak.  To compute a log2 pause index (LPI), we subtracted the DESeq-estimated log2 read count 
(the “rlog” value) for the gene body from the equivalent DESeq-estimated log2 read count at 
the peak.  Furthermore, to compute changes in this value over time, we subtracted the LPI for 
the zero time point from the LPI for each subsequent time point; that is, the change in LPI at 
time t, denoted ΔLPIt, was given by ΔLPIt = LPIt – LPI0.  Notice that normalizing changes in the 
pause peak by changes in the gene body in this way only increases if the number of reads in the 
peak increases by more than the number of reads in the gene body.  
Estimating expression in enhancers 
To prevent contamination from genic transcription, all dTSS previously annotated as 
enhancers were extended by 1 kb to either side and removed if any part of the extended 
enhancer was within 5 kb of a gene body. DESeq was used to estimate the transcription level in 
the enhancer peaks, tails, and the whole enhancer body. The enhancer peak was defined as 
±250 bp from the center of the enhancer, the tail was ±400 to ±1000 bp from the center, and 
the whole enhancer was 0 to ±1000 bp from the center of the enhancer. Read counts were 
summed from both strands for each region (i.e., peak = plus strand [0,+250]+ minus strand[-
250,0]), and then DESeq2 was used to estimate fold changes. Enhancers were called as strongly 
activated if they were differentially expressed with FDR ≤ 0.01, rlog(expression at 0 min) ≤ 1, 
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and were in the 90th percentile for fold change between 0 and 160 minutes. To get the same 
number of similarly expressed non-differentially expressed enhancers, we performed rejection 
sampling on enhancers that were differentially expressed with FDR > 0.5 using their average 
expression values between 0 and 160 minutes and probabilities calculated from a kernelized 
histogram of the activated enhancer’s expression at 160 minutes.   
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Supplemental Material 
 
Supplemental Figure 1. Concordance in read-counts between replicates in gene bodies on the negative strand.  
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Supplemental Figure 2. Transcriptional model for refining dREG calls.  
 
Supplemental Figure 3. Clustering of DE genes into five clusters and summary of enriched cluster-specific terms. 
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Supplemental Figure 4. Clustering of DE genes into seven clusters and summary of enriched cluster-specific terms. 
 
 
Supplemental Figure 5. Full set of Reactome terms enriched in Cluster #1 with respect to the other clusters (FDR <= 
0.01). Annotation similarity indicates what fraction of genes (based upon the term associated with less genes) are shared 
between two terms.  
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Supplemental Figure 6. Full set of Reactome terms enriched in Cluster #2 with respect to the other clusters (FDR <= 
0.01). Annotation similarity indicates what fraction of genes (based upon the term associated with less genes) are shared 
between two terms.  
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Supplemental Figure 7. Expression of HSPB1 and HSPA2, key genes in heat-shock induced translational repression. 
(A) Expression of HSPB1 with each library normalized by size factor and replicates for each time point added together. (B) 
Expression of HSPA1 with each library normalized by size factor and replicates for each time point added together. 
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Supplemental Figure 8. Full set of Reactome terms enriched in Cluster #3 with respect to the other clusters (FDR <= 
0.01). Annotation similarity indicates what fraction of genes (based upon the term associated with less genes) are shared 
between two terms.  
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Supplemental Figure 9. Full set of Reactome terms enriched in Cluster #4 with respect to the other clusters (FDR <= 
0.01). Annotation similarity indicates what fraction of genes (based upon the term associated with less genes) are shared 
between two terms.  
 
 
Supplemental Figure 10. Full set of Reactome terms enriched in Cluster #5 with respect to the other clusters (FDR <= 
0.01). Annotation similarity indicates what fraction of genes (based upon the term associated with less genes) are shared 
between two terms.  
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Supplemental Figure 11.  (A) Weights from the regression model to predict gene expression from ChIP-seq peak scores 
in K562. A positive wieght for a TF at given timepoint means that genes with that TF bound showed increased expression relative 
to those without it. Negative weights mean the opposite. (B) Pre-celastrol treatment ChIP-seq signal for RFX1 grouped by 
clustering based on expression profiles. Each line represents an average over all genes in the cluster in the region of the TSS, 




Supplemental Figure 12. Anatomy of an enhancer. 
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Supplemental Figure 13. TFs that had statistically different DeepBind scores between enhancers which show activation 
and those that are not differentially expressed as categorized by levels of post-pause polymerase.  
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